For instance, in ESCC, elevated NSUN2 levels are associated with advanced tumor stages and reduced patient survival, emphasizing its potential as a prognostic marker (Niu et al., 2022; Su et al., 2021). The gene discussed is NSUN2; the disease is esophageal squamous cell carcinoma.